CAPRA Symposium 2017 - Canada's Drug & Health Product Regulatory Experts

09 June 2017 CAPRA Symposium 2017, SPharm will be present!

In collaboration with the International Generic Drug Regulators Programme (IGDRP) and Health Canada, CAPRA, will host a one day symposium. It will be an ideal opportunity to hear from key international regulators and industry representatives on drivers and the progress of the IGDRP activities and on other initiatives facing regulators and the pharmaceutical industry.

The Canadian Association of Professionals in Regulatory Affairs (CAPRA) is a non-profit organization that serves the pharmaceutical, biologics, medical device, cosmetic and natural health product industries in Canada.

SPharm Canada

With over 20 years of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.

Après plus de 20 ans de résultats et de succès constants, SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d’homologation de leurs médicaments (et autres produits de santé) au Canada.